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Background: We analysed whether a combination of bone- and fall-related risk factors (RFs) in addition to a recent
non-vertebral fracture (NVF) contributed to subsequent NVF risk and mortality during 2-years in patients who were
offered fall and fracture prevention according to Dutch fracture- and fall-prevention guidelines.
Methods: 834 consecutive patients aged ≥50 years with a recent NVF who were included. We compared
subgroups of patients according to the presence of bone RFs and/or fall RFs (group 1: only bone RFs; group 2:
combination of bone and fall RFs; group 3: only fall RFs; group 4: no additional RFs). Univariable and multivariable
Cox regression analyses were performed adjusted for age, sex and baseline fracture location (major or minor).
Results: 57 (6.8%) had a subsequent NVF and 29 (3.5%) died within 2-years. Univariable Cox regression analysis
showed that patients with the combination of bone and fall RFs had a 99% higher risk in subsequent fracture risk
compared to all others (Hazard Ratio (HR) 1.99; 95% Confidence Interval (CI) 1.18-3.36) Multivariable analyses this
was borderline not significant (HR 1.70; 95% CI: 0.99-2.93). No significant differences in mortality were found
between the groups.
Conclusion: Evaluation of fall RFs contributes to identifying patients with bone RFs at highest immediate risk of
subsequent NVF in spite of guideline-based treatment. It should be further studied whether earlier and immediate
prevention following a NVF can decrease fracture risk in patients with a combination of bone and fall RFs.Background
For persons above fifty years of age, a history of fracture
doubles the risk of a subsequent fracture [1]. This risk is
highest immediately after the fracture, with a 5- to 25-
fold increase of subsequent fracture risk within the first
months and years [1-6]. In patients with a recent frac-
ture, other bone-related clinical risk factors, low bone
mineral density (BMD) and fall-related risk factors are
often present [7]. These risk factors are independently
related to fracture risk and are used in algorithms to cal-
culate fracture risk, like FRAXW [8] and Garvan Fracture
Risk calculator [9]. In addition, fall-related risk factors
predict not only the risk of subsequent falls, but also of* Correspondence: k.huntjens@maastrichtuniversity.nl
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reproduction in any medium, provided the orfractures. Therefore, these risk factors are sometimes in-
tegrated in fracture prediction algorithms [9].
Fracture risk reduction has only been shown with spe-
cific anti-osteoporosis medication such as bisphospho-
nates, denosumab, raloxifene and recombinant PTH
[4,10-17]. Fall prevention strategies decrease the risk of
falls, however in these studies prevention of fractures
was not demonstrated [18].
In the field of post fracture care, a Fracture Liaison
Service is one of the initiatives to integrate evaluation of
bone- and fall-related risk factors in patients attending
the hospital with a recent clinical fracture [19].
The aim of the Fracture Liaison Service is to evaluate
bone- and fall-related risk factors, to initiate fall preven-
tion programs, adequate calcium and vitamin D supple-
mentation and specific anti-osteoporosis medication
when needed in order to reduce subsequent falls, frac-
tures and mortality [4,6,11,19-21].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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were assessed at the FLS at Maastricht University Medical
Center for bone- and fall related risk factors and we
hypothesised that over a 2-year follow-up period the sub-
sequent fracture risk and mortality would be highest in
patients with a combination of bone- and fall-related risk
factors, even though these patients received anti-
osteoporosis treatment and/or fall prevention.Methods
Study design
The Fracture Liaison Service is a collaboration between
the department of surgery, orthopaedics and internal
medicine (rheumatology and endocrinology) and is
based on the consensus guideline osteoporosis of the
Dutch Institute for Health Care Improvement (CBO)
[20]. The Fracture Liaison Service is coordinated by a
specialised and dedicated fracture nurse.
Between September 2004 and September 2006 all con-
secutive patients older than 50 years with a recent non-
vertebral fracture, who entered the level one trauma
centre in the south of the Netherlands were invited to
participate. Patients with pathological or vertebral frac-
tures or living outside the postal area were excluded. All
patients were prospectively followed for two years. The
hospital database was searched for radiographically con-
firmed first and subsequent NVF, fracture location and
date of occurrence. All NVFs (baseline and subsequent)
were categorised according to International Classification
of Disease (ICD)-9 and then pooled into 2 groups: major
(hip, pelvis, proximal humerus, proximal tibia, multiple
ribs or distal femur fracture), and minor (all other) frac-
tures [3]. All groups were mutually exclusive. First and
subsequent fractures were classified according to the main
fracture. The national obituary database was searched to
investigate whether patients were deceased.
The study was approved by the medical ethical com-
mittee of the hospital (MEC 03–194).Measurements
All patients, who were able and agreed to evaluate their
fracture risk assessment, were invited to attend the Frac-
ture Liaison Service. Medical history, current and past
medication use, living situation, conditions concerning
the occurrence of the fracture, dietary calcium and vita-
min D intake were assessed. Additionally, bone- and fall-
related risk factors were systematically assessed, and
bone mineral density was measured by dual energy X-ray
absorptiometry (DXA, Hologic QDR 4500) at the lumbar
spine and femoral neck. Based on criteria of the World
Health Organisation osteoporosis was classified as T-score
of ≤ −2.5, osteopenia as T-score between −1.0 and −2.5,
and normal BMD as T-score of >−1.0.According to the national osteoporosis guideline the
following bone- and fall-related risk factors were evalu-
ated: a history of clinical fracture after the age of 50 years,
family history of hip fracture, low body weight (<60 kg),
glucocorticoid use and immobility (<4 hours per day) [20].
Vertebral fractures were excluded from this study, since
the exact date of occurrence is often unclear. Patients
were categorised as having a bone-related risk factor if
they had osteoporosis or at least one of the above men-
tioned risk factors.
According to the national guideline on fall prevention
the following fall-related risk factors were evaluated: a
previous falls in the last 12 months (the fall leading to the
current fracture was excluded), the presence of Parkinson’s
disease, current use of psycho-active medication, urinary
incontinence (defined as involuntary loss of urine) and
articular complaints. Additionally, the Groningen Activity
Restriction Scale (GARS) was used to estimate the dis-
ability in activities of daily living (ADL) [21]. Patients
were categorised as having a fall-related risk factor if at
least one of the risk factors mentioned above was
present or the GARS showed low ADL.
According to the Dutch guidelines on osteoporosis and
fall prevention patients started with Calcium and Vitamin
D or a bisphosphonate in the presence of osteoporosis.
For the analyses, patients were categorised into sub-
groups according to the presence, combination or ab-
sence of bone- and fall-related risk factors: (1) patients
with only bone-related risk factors, (2) patients with
combination of bone- and fall-related risk factors, (3)
patients with only fall-related risk factors, and (4) pa-
tients without bone- or fall-related risk factors. The ra-
tionale behind these groups is that there is a known
treatable risk factor in group 1 and 2, but not in group 3
because in fracture prevention only bone targeted ther-
apy has shown to reduce fracture risk and not fall
targeted therapies.
Statistical analysis
Differences between the groups were analysed using the
chi-square or Fisher’s exact test for categorical variables.
ANOVA and independent samples t-test for numerical
variables. Kaplan-Meier and multivariable Cox regres-
sion analyses were performed using subsequent fracture
and mortality as dependent variables (events), adjusted
for age, sex and baseline fracture location (major/minor).
For subsequent fracture as dependent variable, follow-up
time started at time of current fracture (time = 0) and
was defined as time between current fracture and subse-
quent fracture (= event), death or end of 2-year follow-
up period (= censored). For mortality, follow-up time
was calculated as time between current fracture and death
(= event) or end of 2-year follow-up period (= censored).
Schoenfeld residuals were used to check the proportional
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regression was used. Linearity was checked for continuous
variables and, if violated, centered quadratic terms were
included. A two-sided p-value ≤ 0.05 was considered sta-
tistically significant. All analyses were performed using
SPSS for Mac (version 18.0.0; SPSS Inc., Illinois, USA).
Results
In total 834 patients with a NVF were included. Fifty-
seven (6.8%) patients sustained a subsequent NVF and
29 (3.5%) died within two years.
Table 1 shows the patient characteristics for the total
studied population, and for patients with (n=57) and with-
out a subsequent non-vertebral fracture within 2 years
(n=777). In total, 51.2% of patients had least one bone-
and 60.4% had at least one fall-related risk factor. One in
four patients had a previous clinical fracture at 50+ years,
almost one in five had a low body weight (<60kg) or a
family history with a previous hip fracture. The most com-
mon fall-related risk factors were articular complaints
(31.3%), >1 fall in the preceding year (26.0%) and exposure





Age (SD) 67.3 (10.4) 70
Sex n (%)
Women 608 (72.9) 49
Men 226 (27.1) 8 (
Fracture location n (%)
Major 286 (34.3) 19
Minor 548 (65.7) 38
Bone RFs (%)
Fracture 50+ yrs 218 (26.1) 22
<60 kg 149 (17.9) 11
Positive family history 144 (17.3) 12
Immobility 36 (4.3) 6 (
On glucocorticoids 7 (0.8) 0 (
At least 1 bone RF 427 (51.2) 36
Fall RFs (%)
>1 fall last year 217 (26.0) 21
On psychopharmaca 185 (22.2) 18
Low ADL (before fracture) 61 (7.3) 8 (
Articular complaints 261 (31.3) 17
Urinary incontinence 120 (14.4) 14
Parkinson’s disease 5 (0.6) 0 (
At least 1 of the fall RF 504 (60.4) 39
P-value refers to differences between patients with and without subsequent fractur
Chi-square and Fisher’s exact tests were used for categorical variables and indepen
Abbreviations: ADL: activity of daily living.without a subsequent fracture, patients with a subsequent
fracture were significantly older (70.3 vs. 67.1 years), more
patients had impaired mobility (10.5% vs. 3.9%) and a pre-
vious fracture after the age of 50 (38.6% vs. 25.2%), but less
often had urinary incontinence (24.6% vs. 13.6%). Add-
itionally, patients with a subsequent fracture had more
often a combination of at least one bone-and one fall-
related risk factor (group 2, 56.1% vs. 38.9%, p<0.01) com-
pared to patients without a subsequent fracture.
Subsequent fracture risk
Comparison of subgroups
Table 2 shows the results all patients according to the
pre-specified groups. Patients with the combination of
bone- and fall related risk factors (group 2, n = 334) were
significantly older (70.0 years) compared with group 1
(n = 183, 65.6 years), group 3 (n = 170, 67.6 years) and
group 4 (n = 147, 63.0 years), and were more often fe-
males (83.2%; 69.4% for group 1; 70.6% for group 3, and
56.5% for group 4). They had also sustained more often a
major fracture (42.8%) at baseline compared to the other













(38.6) 196 (25.2) 0.027
(19.3) 138 (17.8) 0.770
(21.1) 132 (17.0) 0.433
10.5) 30 (3.9) 0.017
0) 7 (0.9) 1.000
(63.2) 391 (50.3) 0.061
(36.8) 196 (25.2) 0.054
(31.6) 167 (21.5) 0.077
14.0) 53 (6.8) 0.043
(29.8) 244 (31.4) 0.804
(24.6) 106 (13.6) 0.023
0) 5 (0.6) 1.000
(68.4) 465 (59.8) 0.201
e.
dent-samples t-tests for numerical variables.
















Age (SD) 67.3 (10.4) 65.6 (9.5) 70.0 (10.4) 67.6 (10.8) 63.0 (8.7)
Sex n (%) <0.001
Women 608 (72.9) 127 (69.4) 278 (83.2) 120 (70.6) 83 (56.5)
Men 226 (27.1) 56 (30.6) 56 (16.8) 50 (29.4) 64 (43.5)
Fracture location n (%) <0.001
Major 286 (34.3) 61 (33.3) 143 (42.8) 47 (27.6) 35 (23.8)
Minor 548 (65.7) 122 (66.7) 191 (57.2) 123 (72.4) 112 (76.2)
Subsequent fracture n (%) Total 57 (6.8) 9 (4.9) 32 (9.6) 7 (4.1) 9 (6.1) 0.069
1st year 34 (59.6) 3 (33.3) 22 (68.8) 3 (42.9) 6 (66.7)
2nd year 23 (40.4) 6 (67.7) 10 (31.2) 4 (57.1) 3 (33.3)
Mortality n (%) 29 (3.5) 6 (3.3) 13 (3.9) 7 (4.1) 3 (2.0) 0.728
Chi-square and Fisher’s exact tests were used for categorical variables and ANOVA F-tests for numerical variables.
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was found in absolute subsequent fracture risk between
the groups (p=0.069) (Figures 1, 2 and Table 2).
Patients with a combination of bone- and fall-related risk
factors versus all other patients
Univariable Cox analysis showed that patients with a
combination of risk factors had a significantly higher sub-
sequent fracture risk than all other patients (HR: 1.99,
95% CI: 1.18-3.36 p=0.010) (Figure 3). However, after
adjusting for age, sex and baseline fracture location (mul-
tivariable model) the subsequent fracture risk was not sig-
nificantly higher (borderline) in the multivariable model
(HR 1.70, 95% CI: 0.99-2.93; p=0.055).
Patients with a combination of risk factors compared to
group 1 (only bone-related risk factors)
Patients with the combination of risk factors did not have
a significantly higher subsequent fracture risk than pa-
tients with only bone-related risk factors in univariable
(HR 2.04; 95% CI: 0.97-4.27) or multivariable analyses (HR
1.67; 95% CI: 0.79-3.54). However, the plot of the Kaplan-
Meier curves indicated that the subsequent fractures
occurred immediately after the current fracture in the
combination group, while this was not the case for the pa-
tients with only bone-related risk factors (Figure 4). This
time-dependency was confirmed by the Schoenfeld resid-
uals and the time-dependent Cox regression model (p =
0.024). However, the number of events is too low to draw
reliable conclusions.
Patients with a combination of risk factors compared to
group 3 (only fall-related risk factors)
In univariable analysis, patients with the combination of
risk factors had a higher risk of subsequent fracturescompared with patients with only fall-related risk factors
(HR 2.41, 95% CI: 1.06-6.46). In the multivariable model,
the subsequent fracture risk was no longer significantly
higher (HR 2.05; 95% CI: 0.90-4.69).
Patients with a combination of risk factors compared to
group 4 (no bone- or fall-related risk factors)
No significant differences were found between the
groups on subsequent fracture risk within 2-years after
univariable (HR 1.61; 95% CI: 0.77-3.38) and multivariable
cox regression analyses (HR 1.16; 95% CI: 0.53-2.55).
Mortality
Within two years after baseline fracture 26 patients were
deceased (3.5%). In univariable Cox regression analysis,
no significant difference was found between patients
with a combination of bone- and fall-related risk factors
(group 2) and all other groups, as well as between group
2 and all groups separately. Due to the small number of
deceased patients in the present study, no multivariable
regression analyses were performed. However, this only
reflects the very selected nature of our cohort, as the




The subsequent non-vertebral fracture risk in patients
with a combination of bone- and fall-related risk factors
was nearly double the risk of all other patients in
univariable analysis (HR 1.99 (95% CI: 1.18-3.36). In
multivariable analysis this tendency was also shown, but
it did not reach significance (HR 1.70; 95% CI: 0.99-
2.93). This is partly explained by the low event rate.
There was a time-dependency when comparing patients
AB
Total 9 32 7 9
1st year 3 22 3 6
















Figure 1 All patients according to their pre-specified groups. A Venn diagram. B Histogram.
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bone-related risk factors (data not shown). This indicates
that, in spite of Fracture Liaison Service assessment, pa-
tients with a combination of risk factors still had a high
fracture risk at short term. Many studies have shown that
the risk of subsequent fracture is highest immediately after
a fracture, such as repeat vertebral, hip and non-vertebral
fractures [3,6,22,23]. However, the event rate was lower in
our research compared to other published articles. In a
study among patients aged 60 years and over a relative
risk of subsequent fracture incidence of 1.95 in women
and 3.45 in men was found [3]. A subsequent fracture risk
of 10.8% was found within 2-years after a fracture, and of
17.6% in patients of 50+ years who sustained a NVF after
a NVF [4,5]. The two retrospective studies were per-
formed according to intention-to-treat, and therefore, a
difference in subsequent fracture rate and mortality could
be found. Mortality is known to be increased after a frac-
ture, especially after a hip fracture [24]. A recent study
showed an increased risk of mortality especially within5-years after the fracture [11]. In the described studies,
[3-5,11,24] not all patients were treated at a Fracture
Liaison Service. This might explain the lower subsequent
fracture (6.8%) and mortality rate (3.5%) in our study
compared with the studies mentioned above (due to a
possible treatment effect). In addition, the minimum age
of inclusion was different, and only patients who did at-
tend the Fracture Liaison Service were included.
There was a time-dependency with regard to subse-
quent fracture risk in patients who had both bone- and
fall-related risk factors with the highest risk immediately
after the initial fracture. This might be caused by (new)
falls and, since the bone is already vulnerable due to the
initial fracture, subsequent fractures mostly occur in this
subgroup short-term after the initial fracture.
Therefore, patients with a combination of bone- and
fall-related risk factors, are definitely candidates for imme-
diate fracture prevention combined with fall prevention.
However, of the patients without additional risk factors
6.1% had a subsequent fracture within 2-years of follow-
Figure 2 Multivariable Cox regression analyses stratified
by groups.
Figure 4 Kaplan Maier curve. Fracture free probability of the
combination versus BRF, adjusted for age, sex and baseline
fracture location.
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the bone- and fall- related risk assessment in this study
play a role in the occurrence of subsequent fractures. On
the other hand, all patients in this study had a recent
fracture, which is by itself a major independent risk factor
for subsequent fractures. As a consequence, this might
imply that all patients with an initial NVF, whether or notFigure 3 Kaplan Maier. Cumulative subsequent fracture incidence
in patients with the combination of risk factors (group 2) compared
with all other patients (group 1, 3 and 4).additional risk factors are present, deserve subsequent
fracture prevention regardless of other risk factors. This
is also proposed in the UK guideline [25].
Mortality
No difference was found between the groups for mortal-
ity rate. This could be the result of the low mortality rate
(n=29) in this study in combination with the relatively
short follow-up period (two years). A study with a longer
follow-up period in a larger population is necessary to
further study these findings. Treatment of osteoporosis
with bisphosphonates might reduce mortality rate. The
mechanism by which this operates remains unclear, but
its effect on subsequent fracture risk or on extra skeletal
sites might be two possibilities [11,26,27]. Integrating
guidelines on prevention of falls, fractures and identifica-
tion and treatment of osteoporosis is recommended to
optimise post fracture care. However, integrating these
services is difficult and still has to be achieved in many
centers [28].
Strengths and limitations
The strength of this study is that all consecutive patients
with a recent non-vertebral fracture who attended the
Fracture Liaison Service were included in the analyses.
Furthermore, a dedicated fracture nurse performed the
assessments of well-defined clinical, bone- and fall-related
risk factors according to the national Osteoporosis and
Fall Prevention Guidelines [20,21].
A limitation of this study is that there are no data on
prescription and adherence of the proposed osteoporosis
Huntjens et al. BMC Musculoskeletal Disorders 2013, 14:121 Page 7 of 8
http://www.biomedcentral.com/1471-2474/14/121treatment and fall prevention. Persistence might be low,
as has been shown in a recent publication for oral anti-
osteoporosis medications in the Netherlands [29]. Due
to the low mortality rate, no in depth analysis of the role
of risk factors could be performed. However, this could
also be a strength, since one of the effects of the Fracture
Liaison Service might be mortality risk reduction.
Conclusions
In patients with a recent non-vertebral fracture who had
a combination of bone- and fall-related risk factors, the
risk of subsequent fractures was almost doubled com-
pared with the other patients. These patients also had a
higher subsequent fracture risk immediately after the
initial fracture compared with patients in whom only
bone-related risk factors were present.
Therefore, not only bone- but also fall-related risk fac-
tors should be assessed in order to identify patients at
highest immediate risk of subsequent NVF.
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